Positron Emission Tomography (PET)-Computed Tomography (CT) PET/CT Evaluation of Treatment Response in Breast Cancer
Breast Cancer
Study Type
Study Phase
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Name: Radiopharmaceutical Administration [18F]-FDG Type: Radiation
Name: Radiopharmaceutical: [18F]-FLT Type: Radiation
Overall Status
The purpose of this study is to develop Positron Emission Tomography (PET) - Computed Tomography (CT) PET/CT imaging methods for looking at the effects of chemotherapy in breast cancer.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- Subjects must have histologically proven breast cancer

- Subjects are being considered for preoperative chemotherapy

- Subjects must be ≥ 18 years old.

Exclusion Criteria:

- Children will be excluded from this study.

- Pregnant women and women who are breast feeding will be excluded from this study. (The "PET Procedure Screening Form" will be used to identify and exclude subjects who are pregnant or breastfeeding. A urine pregnancy test/or serum beta HCG will also be performed for women of child bearing potential)

- Patients who are acutely ill who are deemed by their treating physician as not suitable candidates for this study
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Status: Recruiting
Contact: A. Bapsi Chak, MD - bapsi.chak@vanderbilt.edu
Start Date
October 2010
Completion Date
December 2019
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page